SCHEMBL13805035

SCHEMBL13805035

CC1(C)c2ccccc2-c2ccc(-c3nnc(-c4ccc(N(c5ccccc5)c5ccc(-n6c7ccccc7c7ccccc76)cc5)cc4)n3-c3ccccc3)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 4/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AVPR1A P37288 2/20 0.35
AKT1 P31749 1/20 0.33
GLA P06280 1/20 0.33
ALDH1A1 P00352 5/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
PTGER4 P35408 1/20 0.32
MEN1 O00255 1/20 0.31
APEX1 P27695 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
OXTR P30559 2/20 0.31
OPRD1 P41143 1/20 0.31
MAPT P10636 1/20 0.31
AVPR2 P30518 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13805301 0.98 HPGD (0.36) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805256 0.94 HPGD (0.38) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805152 0.94 HPGD (0.37) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805169 0.94 HPGD (0.38) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL10110969 0.93 KDM4E (0.41) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805349 0.92 HPGD (0.36) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL10111127 0.91 AVPR1A (0.40) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805239 0.90 HPGD (0.38) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805043 0.90 KDM4E (0.37) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805302 0.88 HPGD (0.35) HPGDSMN1; SMN2KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device GRIN3A, TEAD2, TBL3 HPGD 1843/4885SMN1; SMN2 4658/4885KDM4E 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.